MedTrace Logo

Biomarkers in Patients With Flesh-eating Bacterial Infections

NCT02180906 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 169

Last updated 2016-02-17

No results posted yet for this study

Summary

The purpose of this study is to investigate the immune response in patients with necrotizing soft tissue infections (NSTI). The investigation will focus on inflammatory and vasoactive biomarkers as prognostic markers of severity and mortality at admission to Rigshospitalet and the following 3 days

Conditions

  • Necrotizing Soft Tissue Infection
  • Necrotizing Fasciitis
  • Gas Gangrene
  • Fournier Gangrene

Sponsors & Collaborators

  • Seventh Framework Programme

    collaborator OTHER

  • Ole Hyldegaard

    lead OTHER

Principal Investigators

  • Marco Bo Hansen, MD · Rigshospitalet, Denmark

  • Ole Hyldegaard, MD, PhD · Rigshospitalet, Denmark

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02180906 on ClinicalTrials.gov